Holmium laser angioplasty

Area of Science:

• Cardiovascular Medicine
• Medical Devices
• Interventional Cardiology

Background:

• Coronary artery disease presents complex lesions unsuitable for traditional balloon angioplasty.
• Plaque ablation and thrombus dissolution are critical in treating ischaemic syndromes and acute myocardial infarction.
• Minimally invasive techniques are sought to improve outcomes in complex coronary interventions.

Purpose of the Study:

• To evaluate the safety and efficacy of a novel solid-state, pulsed-wave, mid-infrared (2.1 microns) holmium:YAG laser system.
• To assess the laser's performance in treating challenging coronary lesions, including thrombotic occlusions and calcified obstructions.
• To determine the laser's impact on restenosis rates in native coronary arteries and saphenous vein grafts.

Main Methods:

• A multicentre study involving the application of a solid-state, pulsed-wave, mid-infrared (2.1 microns) holmium:YAG laser.
• The laser was used for plaque ablation and thrombus dissolution in patients with ischaemic syndromes and acute myocardial infarction.
• Lesions considered 'not ideal' for balloon angioplasty were specifically targeted, including de novo and restenosis lesions.

Main Results:

• The study reported an 87% laser success rate and a 94% final procedural success rate.
• The holmium:YAG laser demonstrated safety and efficacy in treating complex coronary lesions.
• No significant reduction in restenosis rate was observed with the use of this laser technology.

Conclusions:

• The investigational holmium:YAG laser is a safe and effective tool for plaque ablation and thrombus dissolution in complex coronary lesions.
• Appropriate lasing techniques are crucial due to laser-tissue interactions, including gas vapour formation and acoustic wave generation.
• While effective for lesion treatment, the laser does not offer a significant advantage in reducing long-term restenosis rates.